Core Scientific (CORZ) Gains from Investment Securities (2022 - 2026)

Core Scientific (CORZ) has 4 years of Gains from Investment Securities data on file, last reported at $4.8 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities rose 100.75% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $102.3 million (down 87.46% YoY), and the FY2025 full-year result was $34.0 million, down 97.66% from the prior year.
• Gains from Investment Securities eased to $4.8 million in Q1 2026, from $35.7 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.3 billion in Q4 2024 to a low of -$634.3 million in Q1 2025.
• A 4-year average of $80.0 million and a median of -$521000.0 in 2022 frame the typical range for Gains from Investment Securities.
• Across the five-year window, Gains from Investment Securities tumbled 97.33% in 2025 and surged 100.75% in 2026, its largest moves.
• Tracing CORZ's Gains from Investment Securities over 4 years: stood at -$5.0 million in 2022, then soared by 27122.74% to $1.3 billion in 2024, then plunged by 97.33% to $35.7 million in 2025, then slumped by 86.68% to $4.8 million in 2026.
• Business Quant data shows CORZ's Gains from Investment Securities at $4.8 million in Q1 2026, $35.7 million in Q4 2025, and $75.6 million in Q3 2025.